Extending Natalizumab's Use Without Increasing Risk to Patients

Описание к видео Extending Natalizumab's Use Without Increasing Risk to Patients

A lot is known about the benefits of Natalizumab in the treatment of MS patients, but there is also a known risk of patients developing progressive multifocal leukoencephalopathy. Finding a balance between the two conditions was the focus of recent research.

Комментарии

Информация по комментариям в разработке